Announced
Completed
Lincoln Park Capital completed a $40m investment in X4 Pharmaceuticals.
Synopsis
Lincoln Park Capital, a Chicago-based investment group and asset management firm, completed a $40m investment in X4 Pharmaceuticals, a Delaware-incorporated and Boston-headquartered biopharmaceutical company developing novel therapeutics for rare diseases of the immune system.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite